会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Imaging neuroinflammation
    • 成像神经炎症
    • US09481685B2
    • 2016-11-01
    • US13119450
    • 2009-10-02
    • Harry John WadsworthBo ShanDennis O'SheaJoanna Marie PassmoreWilliam John Trigg
    • Harry John WadsworthBo ShanDennis O'SheaJoanna Marie PassmoreWilliam John Trigg
    • A61K51/00A61M36/14C07D495/04A61K51/04
    • C07D495/04A61K51/0446
    • The present invention concerns in vivo imaging and in particular in vivo imaging of the peripheral benzodiazepine receptor (PBR). A tetracyclic indole in vivo imaging agent is provided that binds with high affinity to PBR, has good uptake into the brain following administration, and which preferentially binds to tissues expressing higher levels of PBR. The present invention also provides a precursor compound useful in the synthesis of the in vivo imaging agent of the invention, as well as a method for synthesis of said in vivo imaging agent comprising use of said precursor compound, and a kit for carrying out said method. A cassette for the automated synthesis of the in vivo imaging agent is also provided. In addition, the invention provides a radiopharmaceutical composition comprising the in vivo imaging agent of the invention, as well as methods for the use of said in vivo imaging agent.
    • 本发明涉及体内成像,特别是周边苯二氮卓受体(PBR)的体内成像。 提供四环吲哚体内显像剂,其以高亲和力与PBR结合,在给药后具有良好的摄入脑中,并优先结合表达较高水平的PBR的组织。 本发明还提供了可用于合成本发明的体内显像剂的前体化合物,以及包含使用所述前体化合物的所述体内显像剂的合成方法和用于实施所述方法的试剂盒 。 还提供了用于体内成像剂的自动合成的盒。 此外,本发明提供了包含本发明的体内显像剂的放射性药物组合物,以及使用所述体内显像剂的方法。
    • 5. 发明申请
    • IMAGING NEUROINFLAMMATION
    • 成像神经炎症
    • US20110190618A1
    • 2011-08-04
    • US13119450
    • 2009-10-02
    • Harry John WadsworthBo ShanDennis O' SheaJoanna Marie PassmoreWilliam John Trigg
    • Harry John WadsworthBo ShanDennis O' SheaJoanna Marie PassmoreWilliam John Trigg
    • A61B6/00C07D495/04A61K51/00A61B19/00
    • C07D495/04A61K51/0446
    • The present invention concerns in vivo imaging and in particular in vivo imaging of the peripheral benzodiazepine receptor (PBR). A tetracyclic indole in vivo imaging agent is provided that binds with high affinity to PBR, has good uptake into the brain following administration, and which preferentially binds to tissues expressing higher levels of PBR. The present invention also provides a precursor compound useful in the synthesis of the in vivo imaging agent of the invention, as well as a method for synthesis of said in vivo imaging agent comprising use of said precursor compound, and a kit for carrying out said method. A cassette for the automated synthesis of the in vivo imaging agent is also provided. In addition, the invention provides a radiopharmaceutical composition comprising the in vivo imaging agent of the invention, as well as methods for the use of said in vivo imaging agent.
    • 本发明涉及体内成像,特别是周边苯二氮卓受体(PBR)的体内成像。 提供四环吲哚体内显像剂,其以高亲和力与PBR结合,在给药后具有良好的摄入脑中,并优先结合表达较高水平的PBR的组织。 本发明还提供了可用于合成本发明的体内显像剂的前体化合物,以及包含使用所述前体化合物的所述体内显像剂的合成方法和用于实施所述方法的试剂盒 。 还提供了用于体内成像剂的自动合成的盒。 此外,本发明提供了包含本发明的体内显像剂的放射性药物组合物,以及使用所述体内显像剂的方法。
    • 6. 发明申请
    • CONTRAST AGENTS
    • 对比剂
    • US20100221189A1
    • 2010-09-02
    • US12682298
    • 2008-10-10
    • Ian Martin NewingtonDuncan George WynnVeronique Morisson-IvesonJoanna Marie Passmore
    • Ian Martin NewingtonDuncan George WynnVeronique Morisson-IvesonJoanna Marie Passmore
    • A61K49/04C07C233/15C07D241/04C07D211/56
    • A61K49/0438C07C237/46C07C2601/14C07D211/58C07D295/108
    • The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds containing two linked iodinated phenyl groups of the general formula (I) and salts or optical active isomers thereof, wherein each R1 independently are the same or different and denotes a hydrogen atom or a C1 to C4 straight or branched alkyl group which is optionally substituted by 1 to 4 —OH groups; each of R2 independently are the same or different and denote a hydrogen atom or a C1 to C4 straight or branched alkyl group; each R3 independently are the same or different and denotes a hydrogen atom or a C1 to C4 straight or branched alkyl group which is optionally substituted by 1 to 4 —OH groups; each R4 independently are the same or different and denote C1 to C6 straight or branched alkyl moieties substituted by up to 6 —OH groups; and each R5 independently are the same or different and denote C1 to C6 straight or branched alkyl moieties substituted by up to 6 —OH groups; and X denotes a straight chain alkylene moiety with 3 to 10 carbon atoms, a 1,4-cyclohexylene group, or X together with the adjacent —NR1 groups forms a 1,4-piperazine group or a 4-aminopiperidine group. The invention also relates to the use of such diagnostic compositions as contrast agents in diagnostic imaging and in particular in X-ray imaging, and to contrast media containing such compounds.
    • 本发明涉及一类化合物和含有这些化合物的诊断组合物,其中化合物是含碘化合物。 更具体地说,含碘化合物是含有通式(I)的两个连接的碘化苯基和其盐或光学活性异构体的化合物,其中每个R 1独立地相同或不同,表示氢原子或C1至C4直链 或任选被1至4个-OH基团取代的支链烷基; R2各自相同或不同,表示氢原子或C1〜C4直链或支链烷基; 每个R 3独立地相同或不同,表示氢原子或任选被1至4个-OH基团取代的C 1至C 4直链或支链烷基; 每个R 4独立地相同或不同,表示被至多6个-OH基团取代的C1至C6直链或支链烷基部分; 并且每个R 5独立地相同或不同,表示被至多6个-OH基团取代的C 1至C 6直链或支链烷基部分; X表示具有3至10个碳原子的直链亚烷基部分,1,4-亚环己基或X与相邻的-NR1基团一起形成1,4-哌嗪基团或4-氨基哌啶基团。 本发明还涉及这种诊断组合物作为造影剂在诊断成像中,特别是在X射线成像中的用途,以及含有这些化合物的造影剂。